Fundraising FoxBetter Ventures Central Llc — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing.
BiotechHealthtechMedical DevicesNew MaterialsChicago, US
Caralynn Nowinski Collens(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Co-founder & CSO)Adam Jakus(Co-Founder)inRamille S.(Founder)inLarry Weinstein(SVP, Manufacturing & Quality Operations)
Co-investorsAlumni VenturesGaingelsHarvard Business Angels of ChicagoHAWKTAILLofty VenturesPathway Bioventures+5 more
__Twitter.png)
KETOS develops an automated water quality and monitoring platform combining hardware, connectivity, software, and services to test water safety and efficiency for cities and businesses.
AI & Machine LearningCleantechData & InfrastructureEnterprise SoftwareIoTMilpitas, US
Meena Sankaran(Executive Officer, Director)inVeery Maxwell(Director)
BoardHeidi Patel(Director)inOllen Douglass(Director)
Co-investorsRethink ImpactMotley Fool VenturesPlug and Play VenturesPlum Alley InvestmentsThe Perkins FundAccenture Ventures
Lassogen engineers lasso peptides — structurally unique 3D scaffolds — into therapeutics it calls Lassotides, designed to combine the strengths of antibodies and small molecules.
AI & Machine LearningBiotechSan Diego, US
Mark J Burk(Executive Officer)in
Co-investorsFirst In VenturesPlayground Global
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Chi Botanic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.